Melissa F. Adasme
Melissa F. Adasme
PhD student
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
PLIP: fully automated protein–ligand interaction profiler
S Salentin, S Schreiber, VJ Haupt, MF Adasme, M Schroeder
Nucleic acids research 43 (W1), W443-W447, 2015
From malaria to cancer: Computational drug repositioning of amodiaquine using PLIP interaction patterns
S Salentin, MF Adasme, JC Heinrich, VJ Haupt, S Daminelli, Y Zhang, ...
Scientific reports 7 (1), 1-13, 2017
Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
D Parisi, MF Adasme, A Sveshnikova, SN Bolz, Y Moreau, M Schroeder
Computational and Structural Biotechnology Journal 18, 1043-1055, 2020
Controlling distinct signaling states in cultured cancer cells provides a new platform for drug discovery
SW Poser, O Otto, C Arps-Forker, Y Ge, M Herbig, C Andree, ...
The FASEB Journal, 2019
Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor
MF Adasme, D Parisi, K Van Belle, S Salentin, VJ Haupt, GS Jennings, ...
Plos one 15 (5), e0233089, 2020
Structure-based drug repositioning: Potential and limits
MF Adasme, D Parisi, A Sveshnikova, M Schroeder
Seminars in cancer biology, 2020
PLIP 2021: expanding the scope of the protein–ligand interaction profiler to DNA and RNA
MF Adasme, KL Linnemann, SN Bolz, F Kaiser, S Salentin, VJ Haupt, ...
Nucleic Acids Research, 2021
Toward an Understanding of Pan-Assay Interference Compounds and Promiscuity: A Structural Perspective on Binding Modes
SN Bolz, MF Adasme, M Schroeder
Journal of Chemical Information and Modeling, 2021
Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
MF Adasme, SN Bolz, L Adelmann, S Salentin, VJ Haupt, ...
International journal of molecular sciences 21 (22), 8809, 2020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–9